Reduction of postsurgical adhesions in a rat model: a comparative study

Clinics (Sao Paulo). 2009;64(2):143-8. doi: 10.1590/s1807-59322009000200012.

Abstract

Background: Adhesion formation after peritoneal surgery is a major cause of postoperative bowel obstruction, infertility, and chronic pelvic pain. In this study, we compared the possible individual effects of phosphatidylcholine (PC), Seprafilm II, and tissue plasminogen activator (t-PA) and the combined effects of phosphatidylcholine and t-PA on postoperative adhesion formation in a rat surgical model.

Materials and methods: A total of 50 Wistar male rats underwent median laparotomy and standardized abrasion of the visceral and parietal peritoneum. phosphatidylcholine, Seprafilm II, and t-PA alone and phosphatidylcholine and t-PA in combination were applied intraperitoneally at the end of the surgical procedure. Seven days after surgery, a relaparotomy was performed for adhesion grading and histopathological examination.

Results: A comparison of adhesion stages demonstrated a significant difference between the control group and the study groups (p<0.001). The adhesion grade of the combined treatment group was statistically different from that of the other groups (p<0.05). In the t-PA group and the combined group, six and two rats, respectively, developed hematomas locally on the cecum.

Conclusions: PC, t-PA, and Seprafilm II used individually reduced the adhesion grade. The t-PA and phosphatidylcholine combination was most effective in reducing adhesion formation. On the other hand, usage of t-PA alone or in combination may increase risk of bleeding. More detailed studies are needed, and future studies on the efficacy of a material for decreasing adhesion formation should include a comparison of several control materials in the same model.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Drug Combinations
  • Drug Evaluation, Preclinical
  • Drug Therapy, Combination
  • Fibrinolytic Agents / therapeutic use*
  • Hyaluronic Acid / therapeutic use*
  • Male
  • Peritoneal Diseases / drug therapy*
  • Peritoneal Diseases / prevention & control
  • Phosphatidylcholines / therapeutic use*
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / prevention & control
  • Rats
  • Rats, Wistar
  • Tissue Adhesions / drug therapy
  • Tissue Adhesions / prevention & control
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Drug Combinations
  • Fibrinolytic Agents
  • Phosphatidylcholines
  • Seprafilm
  • Hyaluronic Acid
  • Tissue Plasminogen Activator